These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 7471090)
1. Inhibition of growth of colorectal carcinoma in nude mice by monoclonal antibody. Herlyn DM; Steplewski Z; Herlyn MF; Koprowski H Cancer Res; 1980 Mar; 40(3):717-21. PubMed ID: 7471090 [TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibodies in cell-mediated cytotoxicity against human melanoma and colorectal carcinoma. Herlyn D; Herlyn M; Steplewski Z; Koprowski H Eur J Immunol; 1979 Aug; 9(8):657-9. PubMed ID: 499332 [TBL] [Abstract][Full Text] [Related]
3. Mechanisms of tumor growth inhibition. Steplewski Z; Herlyn D; Lubeck M; Kimoto Y; Herlyn M; Koprowski H Hybridoma; 1986 Jul; 5 Suppl 1():S59-64. PubMed ID: 3744386 [No Abstract] [Full Text] [Related]
4. Chimeric (mouse/human) anti-colon cancer antibody c30.6 inhibits the growth of human colorectal cancer xenografts in scid/scid mice. Mount PF; Sutton VR; Li W; Burgess J; McKEnzie IF; Pietersz GA; Trapani JA Cancer Res; 1994 Dec; 54(23):6160-6. PubMed ID: 7954462 [TBL] [Abstract][Full Text] [Related]
5. Preclinical studies on the pharmacokinetic properties of human monoclonal antibodies to colorectal cancer and their use for detection of tumors. McCabe RP; Peters LC; Haspel MV; Pomato N; Carrasquillo JA; Hanna MG Cancer Res; 1988 Aug; 48(15):4348-53. PubMed ID: 3390831 [TBL] [Abstract][Full Text] [Related]
6. Production of monoclonal antibodies using spleen cells from nude mice bearing human tumors. Al Saati T; Blancher A; Calvas P; Neulat-Duga I; Delsol G Ann Pathol; 1987; 7(1):1-8. PubMed ID: 3040026 [TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibodies to human tumor antigens. Steplewski Z Transplant Proc; 1980 Sep; 12(3):384-7. PubMed ID: 7222217 [No Abstract] [Full Text] [Related]
8. Inhibition of human tumor growth by IgG2A monoclonal antibodies correlates with antibody density on tumor cells. Herlyn D; Powe J; Ross AH; Herlyn M; Koprowski H J Immunol; 1985 Feb; 134(2):1300-4. PubMed ID: 3965572 [TBL] [Abstract][Full Text] [Related]
9. Tumorigenicity in athymic mice of the human colon carcinoma cell line SW1116 expressing the tumor-associated antigenic determinant CA 19-9. Klug TL; Salzman S; Quinn A; Melincoff GA; Sedmak DD; Tubbs RR; Zurawski VR Cancer Res; 1984 Nov; 44(11):5212-8. PubMed ID: 6207914 [TBL] [Abstract][Full Text] [Related]
10. Construction and in vivo evaluation of an anti-PSA x anti-CD3 bispecific antibody for the immunotherapy of prostate cancer. Katzenwadel A; Schleer H; Gierschner D; Wetterauer U; Elsässer-Beile U Anticancer Res; 2000; 20(3A):1551-5. PubMed ID: 10928069 [TBL] [Abstract][Full Text] [Related]
11. Tumor growth suppression by a mouse/human chimeric anti-CEA antibody and lymphokine-activated killer cells in vitro and in SCID mouse xenograft model. Senba T; Kuroki M; Arakawa F; Yamamoto T; Kuwahara M; Haruno M; Ikeda S; Matsuoka Y Anticancer Res; 1998; 18(1A):17-24. PubMed ID: 9568050 [TBL] [Abstract][Full Text] [Related]
12. Immunotherapy with low and high affinity monoclonal antibodies 17-1A and 323/A3 in a nude mouse xenograft carcinoma model. Velders MP; van Rhijn CM; Briaire IH; Fleuren GJ; Warnaar SO; Litvinov SV Cancer Res; 1995 Oct; 55(19):4398-403. PubMed ID: 7671252 [TBL] [Abstract][Full Text] [Related]
13. Cocktails of human anti-cancer antibodies show a synergistic effect in nude mouse tumor xenografts. Glassy MC; McKnight ME; Kotlan B; Glassy EF; Koda K Hum Antibodies; 2007; 16(3-4):87-98. PubMed ID: 18334744 [TBL] [Abstract][Full Text] [Related]
14. Characterization of monoclonal antibodies to human melanoma-associated antigens. Imai K; Ng AK; Ferrone S J Natl Cancer Inst; 1981 Mar; 66(3):489-96. PubMed ID: 6162991 [TBL] [Abstract][Full Text] [Related]
15. Specific targeting and killing activities of anti-P-glycoprotein monoclonal antibody MRK16 directed against intrinsically multidrug-resistant human colorectal carcinoma cell lines in the nude mouse model. Iwahashi T; Okochi E; Ariyoshi K; Watabe H; Amann E; Mori S; Tsuruo T; Ono K Cancer Res; 1993 Nov; 53(22):5475-82. PubMed ID: 8106147 [TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibodies specific immunotherapy of gastrointestinal tumors. Douillard JY; Lehur PA; Vignoud J; Blottière H; Maurel C; Thedrez P; Kremer M; Le Mevel B Hybridoma; 1986 Jul; 5 Suppl 1():S139-49. PubMed ID: 3527945 [TBL] [Abstract][Full Text] [Related]
17. [Enhancing effect by anti-cancer drugs on growth inhibition of colon carcinoma in nude mice by monoclonal antibody and complement]. Sakita M; Hata K; Iwamoto A; Kitamura K; Suzuyama H; Takahashi T Nihon Gan Chiryo Gakkai Shi; 1989 May; 24(5):999-1006. PubMed ID: 2778387 [TBL] [Abstract][Full Text] [Related]
18. Efficient inhibition of intra-peritoneal tumor growth and dissemination of human ovarian carcinoma cells in nude mice by anti-L1-cell adhesion molecule monoclonal antibody treatment. Arlt MJ; Novak-Hofer I; Gast D; Gschwend V; Moldenhauer G; Grünberg J; Honer M; Schubiger PA; Altevogt P; Krüger A Cancer Res; 2006 Jan; 66(2):936-43. PubMed ID: 16424028 [TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor is an in vivo survival factor for tumor endothelium in a murine model of colorectal carcinoma liver metastases. Bruns CJ; Liu W; Davis DW; Shaheen RM; McConkey DJ; Wilson MR; Bucana CD; Hicklin DJ; Ellis LM Cancer; 2000 Aug; 89(3):488-99. PubMed ID: 10931447 [TBL] [Abstract][Full Text] [Related]